College of Laboratory Medicine, Jilin Medical University, Jilin 132000, China.
Medical College, Yanbian University, Yanji 136200, China.
Molecules. 2022 May 7;27(9):3003. doi: 10.3390/molecules27093003.
P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular nucleotides. The P2Y2 receptor subtype is expressed in a variety of cell types and plays an important role in physiological and pathophysiological processes such as inflammatory responses and neuropathic pain. Based on this, the P2Y2 has been identified as an important drug target. The specificity of current P2Y2 receptor modulators is relatively poor, and currently, specific and efficient P2Y2 receptor modulators and efficient screening strategies are lacking. In this study, a cell model based on calcium-activated chloride channels (CaCCs) was established that can detect changes in intracellular calcium concentrations and can be used to high-throughput screen for P2Y2 receptor-specific regulators. This screening strategy is suitable for screening of most G-protein-coupled receptor regulators that mediate increases in intracellular calcium signals. The cell model consists of three components that include the endogenously expressed P2Y2 receptor protein, the exogenously expressed calcium-activated chloride channel Anoctamin-1 (Ano1), and a yellow fluorescent protein mutant expressed within the cell that is highly sensitive to iodine ions. This model will allow for high-throughput screening of GPCR regulators that mediate increased intracellular calcium signaling using the calcium-activated transport of iodide ions by Ano1. We verified the ability of the model to detect intracellular calcium ion concentration using fluorescence quenching kinetic experiments by applying existing P2Y2 agonists and inhibitors to validate the screening function of the model, and we also evaluated the performance of the model in the context of high-throughput screening studies. The experimental results revealed that the model could sensitively detect intracellular calcium ion concentration changes and that the model was accurate in regard to detecting P2Y2 modulators. The resultant value of the Z-factor was 0.69, thus indicating that the model possesses good sensitivity and specificity.
P2Y 受体是细胞外核苷酸的 G 蛋白偶联受体 (GPCR)。P2Y2 受体亚型在多种细胞类型中表达,在炎症反应和神经病理性疼痛等生理和病理生理过程中发挥重要作用。基于此,P2Y2 已被确定为一个重要的药物靶点。目前的 P2Y2 受体调节剂的特异性相对较差,目前缺乏特异性和高效的 P2Y2 受体调节剂和有效的筛选策略。在这项研究中,建立了一种基于钙激活氯离子通道 (CaCC) 的细胞模型,该模型可以检测细胞内钙离子浓度的变化,可用于高通量筛选 P2Y2 受体特异性调节剂。这种筛选策略适用于筛选大多数介导细胞内钙离子信号增加的 G 蛋白偶联受体调节剂。该细胞模型由三个部分组成,包括内源性表达的 P2Y2 受体蛋白、外源性表达的钙激活氯离子通道 Anoctamin-1 (Ano1) 和细胞内表达的对碘离子高度敏感的黄色荧光蛋白突变体。该模型将允许使用 Ano1 介导的碘离子钙激活转运来高通量筛选介导细胞内钙离子信号增加的 GPCR 调节剂。我们通过应用现有的 P2Y2 激动剂和抑制剂来验证模型检测细胞内钙离子浓度的能力,验证了模型的筛选功能,还评估了模型在高通量筛选研究中的性能。实验结果表明,该模型能够灵敏地检测细胞内钙离子浓度变化,并且模型在检测 P2Y2 调节剂方面具有准确性。Z 因子的实得值为 0.69,表明该模型具有良好的灵敏度和特异性。